pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Fierce Biotech·4d ago·1 min read
save

ARPA-H launches SPECTRA program to advance autism diagnosis and precision care

Sep 17, 2026·read at Fierce Biotech ↗RegulatoryPositive

ARPA-H announced the launch of the Systems for Phenotypic Evaluation, Clinical Trajectories, Response, and Agency (SPECTRA) program, a new effort aimed at transforming autism diagnosis and precision care.

The initiative will combine advanced computational tools with real‑world data to create an end‑to‑end system that identifies autism spectrum disorder risk factors and connects patients to appropriate interventions.

Researchers plan to work closely with stakeholders and advocacy groups, integrating objective biological data to accelerate clinical research for new therapies.

HHS Secretary Robert F. Kennedy Jr. highlighted the need for personalized approaches given autism’s variability and said the program will harness science and innovation to improve outcomes for individuals and families.

source

This writeup was produced by pharmadog from original reporting by Fierce Biotech.

Original headline: “ARPA-H launches SPECTRA program, new autism research initiative”

read at Fierce Biotech ↗
700 words · retrieved 2d ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Boundless Bio, Inc.National Institutes of Health
drugs
ACETAMINOPHEN AND IBUPROFENHYDROCODONE BITARTRATE AND ACETAMINOPHENOXYCODONE AND ACETAMINOPHEN
topics
Vaccines2AdCom

related stories

  • 4d agoKennedy announces new effort to speed up autism diagnosesSTAT
  • Apr 30STAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHASTAT
  • Sep 14After a brief storm of political headwinds, mRNA is back with strong momentumBioSpace
  • Aug 6Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he wasSTAT
  • Jun 18Six of the biggest health news stories todaySTAT